Penile rehabilitation and neuromodulation

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 652-664

  Facio Jr , Fernando ^a   Burnett, Arthur L ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Erectile dysfunction; Penile erectile; Prostate cancer; Radical prostatectomy

Indexed keywords

ATORVASTATIN; BETAMETHASONE; CORTICOSTEROID; ERYTHROPOIETIN; GPI 1485; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOPHILIN; LIPOCORTIN 1; METHYLPREDNISOLONE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; PROSTAVASIN; SILDENAFIL; TACROLIMUS; VARDENAFIL; ANTIINFLAMMATORY AGENT; LIGAND; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN;

BEDTIME DOSAGE; BRAIN INJURY; CANCER SURGERY; CLINICAL TRIAL; ELECTRODE; ERECTILE DYSFUNCTION; GENE THERAPY; HEART MUSCLE INJURY; HUMAN; KIDNEY INJURY; LOW DRUG DOSE; MEDICAL INSTRUMENTATION; NERVE TRANSPLANTATION; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PENILE REHABILITATION; PENIS PROSTHESIS; PROSTATE CANCER; PROSTATECTOMY; REGENERATIVE MEDICINE; REHABILITATION; REVIEW; VACCUM ERECTION DEVICE; INNERVATION; MALE; PENIS; VACUUM;

ANTI-INFLAMMATORY AGENTS; ELECTRODES; ERECTILE DYSFUNCTION; ERYTHROPOIETIN; GENE THERAPY; HUMANS; LIGANDS; MALE; PENIS; PHOSPHODIESTERASE INHIBITORS; PROSTAGLANDINS; PROSTATECTOMY; VACUUM;

EID: 70350767298     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.86     Document Type: Review

References (72)

1. Burnett, A.L. (2005) Erectile dysfunction following radical prostatectomy. JAMA 293, 2648-2653. (Pubitemid 40741202)
2. Bill-Axelson, A., Holmberg, L., Ruutu, M., Haggman, M., Anderson, S.O., Bratell, S., et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 19, 1977-1984. (Pubitemid 40638368)
3. Burnett, A.L., Aus, G., Canby-Hagino, E.D., Cookson, M.S., D'Amico, A.V., Dmochowski, R.R., et al. (2007) Erectile function outcome reporting after clinically localized prostate cancer treatment. J. Urol. 178, 597-601. (Pubitemid 47030514)
4. Burnett, A.L. (2007) Treatment Strategies for Erectile Dysfunction. Oxford, U.K. Chap. 17, pp. 247-260.
5. Menon, M., Kaul, S., Bhadari, A., Shrivastava, A., Tewari, A., and Hemal, A. (2005) Potency following robotical radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques. J. Urol. 174, 2291-2296. (Pubitemid 41611806)
6. Patel, V., Palmer, K.J, Coughlin, G., and Samavedi, S. (2005) Robot-assisted laparoscopic radical prostatectomy: perioperative outcomes of 1500 cases. J. Endourol. 22, 2299-2305.
7. Hu, J., Wang, Q., Pashos, C.L., Lipsitz, S.R., and Keating, N.L. (2008) Utilization and outcomes of minimally invasive radical prostatectomy. J. Clin. Oncol. 28, 2278-2284.
8. Hakimi, A., Feder, M., and Ghavamian, R. (2007) Minimally invasive approaches to prostate cancer: a review of the current literature. Urol. J. 4, 130-137.
9. Matsunaga, G., Ahlering, T.E., and Skarecky, D.W. (2006) Update on robotic laparoscopic radical prostatectomy. TheScientificWorldJOURNAL 6, 2542-2552.
10. Sanda, M., Dunn, R.L., Michalski, J., Sandler, H.M., Northouse, L., Hembroff, L., et al. (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250-1261.
11. Jamal, K., Patel, P., and Sooriakumaran, P. (2008) Minimally invasive surgical modalities in the management of localized prostate cancer. Expert Rev. Anticancer Ther. 8, 957-966.
12. Asterling, S. and Greene, D.R. (2008) Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer. BJU Int. 103(6), 788-792.
13. Incrocci, L., Slob, A.K., and Levendag, P.C. (2002) Sexual (dys)function after radiotherapy for prostate cancer: a review. Int. J. Radiat. Oncol. Biol. Phys. 52, 681-693. (Pubitemid 34158730)
14. Pinkawa, M., Gagel, B., Piroth, M.D, Fischedick, K., Asadpour, B., Kehl, M., et al. (2008) Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur. Urol. [Epub ahead of print]
15. Stone, N., Ramin, S.A., Wesson, M.F., Stock, R., Unger, P., and Klein, G. (1995) Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate. J. Urol. 153, 1555-1560.
16. Teloken, P., Ohebshalom, M., Mohideen, N., and Mulhall, J.P. (2007) Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer. J. Urol. 178, 2521-2525. (Pubitemid 350052155)
17. Mulhall, J.P. and Graydon, R.J. (1996) The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int. J. Impot. Res. 8, 91-94.
18. Burnett, A.L. (2003) Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 61, 491-497.
19. Raina, R., Pahlajani, G., Agarwal, A., and Zippe, C.D. (2008) Early penile rehabilitation following radical prostatectomy: Cleveland Clinic experience. Int. J. Impot. Res. 20, 121-126.
20. Rambhatla, A., Kovanecz, I., Ferrini, M., Gonzales-Cadavid, N.F., and Rajfer, J. (2008) Rationale for phosphodiesterase 5 inhibitor use post-radical prostatectomy: experimental and clinical review. Int. J. Impot. Res. 20, 30-34.
21. Mulhall, J.P., Slovick, R., Hotaling, J., Aviv, N., Valenzuela, R., Waters, W.B., et al. (2002) Erectile dysfunction after radical prostatectomy: hemodymanic profiles and their correlation with the recovery of erectile function. J. Urol. 167, 1371-1375. (Pubitemid 34132096)
22. Mulhall, J.P., Secin, F.P., and Guillonneau, B. (2008) Artery sparing radical prostatectomy: myth or reality? J. Urol. 179, 827-831.
23. Donatucci, C.F. and Greenfield, J.M. (2006) Recovery of sexual function after prostate cancer treatment. Curr. Opin. Urol. 16(6), 444-448. (Pubitemid 44624579)
24. Rogers, C., Trock, B.P., and Walsh, P.C. (2004) Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results. Urology 64, 148-151. (Pubitemid 38887597)
25. Burnett, A.L. (2008) Erectile dysfunction management for the future. J. Androl. [Epub ahead of print]
26. Goldstein, I., Lue, T.F., Padma-Nathan, H., Rosen, R.C., Steers, W.D., Wicker, P.A., et al. (1998) Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 338, 1397-1404. (Pubitemid 28221980)
27. Hatzimouratidis, K., Burnett, A.L., Hatzichristou, D., McCullough, A.R., Montorsi, F., and Mulhall, J.P. (2008) Phosphodiesterase type 5 inhibitors in post-prostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur. Urol. [Epub ahead of print].
28. Gralnek, D., Wessells, H., Cui, H., and Dalkin, B.L. (2000) Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J. Urol. 163, 1166-1170. (Pubitemid 30169384)
29. Gontero, P. and Kirby, R. (2004) Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP). Prostate Cancer Prostatic Dis. 7, 223-226. (Pubitemid 41741507)
30. Mulhall, J. (2008) Penile rehabilitation following radical prostatectomy. Curr. Opin. Urol. 18, 613-620.
31. Kovanecz, I., Rambhatla, A., Ferrini, M., Vernet, D., Sanchez, S., Rajfer, J., et al. (2008) Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction CVOD) induced by cavernosal nerve resection in rats. Int. J. Impot. Res. 20, 202-212.
32. Wang, R. (2007) Penile rehabilitation after radical prostatectomy: where do we stand and where are we going? J. Sex. Med. 4, 1085-1097. (Pubitemid 47079603)
33. Giuliano, F., Amar, E., Chevallier, D., Montaigne, O., Joubert, J.M., and Chartier-Kastler, E. (2008) How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J. Sex. Med. 5, 448-457. (Pubitemid 351167753)
34. Padma-Nathan, H., McCullough, A., and Forest, C. (2004) Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies. Curr. Urol. Rep. 5, 467-471.
35. Mulhall, J., Land, S., Parker, M., Waters, W.B., and Flanigan, R.C. (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erection function. J. Sex. Med. 2, 532-550.
36. Bannowsky, A., Schulze, H., van der Horst, C., Hautmann, S., and Jünemann, K.P. (2008) Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 101, 1279-1283. (Pubitemid 351549634)
37. Padma-Nathan, H., McCullough, A.R., Giuliano, F., Toler, S.M., et al. (2003) Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J. Urol. 169(4), 375.
38. Montorsi, F., Maga, T., Strambi, L.F., Salonia, A., Barbieri, L., Scattoni, V., et al. (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 56, 906-911.
39. Montorsi, F., Brock, G., Lee, J., Shapiro, J.D., Van, H., Graefen, M., and Stief, C. (2008) Effect of nightly versus ondemand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur. Urol. 54, 924-931.
40. Hellstrom, W.J., Bennett, A.H., Gesundheit, N., Kaiser, F.E., Lue, T.F., Padma-Nathan, H., et al. (1996) A doubleblind, placebo controlled evaluation of the erectile response to transurethral alprostadil. Urology 48, 851-856. (Pubitemid 26427091)
41. Raina, R., Pahlajani, G., Agarwal, A., and Zippe, C. (2007) The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int. 100, 1317-1321. (Pubitemid 350043898)
42. Raina, R., Lakin, M., Thukral, M., Agarwal, A., Ausmundson, S., Montague, D.K., et al. (2003) Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy:SHIM (IIEF- 5) analysis. Int. J. Impot. Res. 15, 318-322. (Pubitemid 37376935)
43. Montorsi, F., Guazzoni, G., and Strambi, L.F. (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J. Urol. 158, 1408-1410. (Pubitemid 27391208)
44. Raina, R., Agarwal, A., Ausmundson, S., Lakin, M., Nandipati, K.C., Mansour, D., et al. (2006) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int. J. Impot. Res. 18, 77-81. (Pubitemid 43050026)
45. Köhler, T., Pedro, R., Hendlin, K., Utz, W., Ugarte, R., Reddy, P., et al. (2007) A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 100, 858-862. (Pubitemid 47360201)
46. Burnett, A.L. and Lue, T.F. (2006) Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery. J. Urol. 176, 882-887.
47. Burnett, A.L. (2007) Nerve regeneration: grafts, conduits, and strategies. In Textbook of Reconstructive Urologic Surgery. Montague, D., Ross, J., Gill, I., and Angermeier, K., Eds. Taylor & Francis. Chap. 93, pp. 781-789.
48. Parsons, J.K., Marschke, P., Maples, P., and Walsh, P.C. (2004) Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. Urology 64, 987-990. (Pubitemid 39469519)
49. Deliveliotis, C., Delis, A., Papatsoris, A., Antoniou, N., and Varkarakis, I.M. (2005) Local steroid appication during nerve-sparing radical prostatectomy. BJU Int. 96, 533-535. (Pubitemid 41224322)
50. Sezen, S.F., Hoke, A., Burnett, A.L., and Snyder, S.H. (2001) Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat. Med. 7, 1073.
51. Lagoda, G., Lebrfeld, T., Jin, L., Liu, T., and Burnett, A.L. (2007) FK506 and sildenafil promote erectile function recovery after cavernosus nerve injury through anti-oxidative mechanisms. J. Sex. Med. 4, 908-916. (Pubitemid 47082255)
52. Burnett, A.L., McCullough, A., Smith, J., Montie, J., Walsh, P.C., and Steiner, J. (2007) Neuromodulation to preserve erectile function after radical prostatectomy: results from the GPI1485 neuroimmunophilin ligand clinical trial. American Urological Association Meeting. J. Urol. 177(4 Suppl), Abstract 1162.
53. A Safety and efficacy study of Prograf in the prevention of erectile dysfunction after radical prostatectomy. Clinical Trials.gov. Available at: http://clinicaltrials.gov/ct/show/NCT00106392.
54. Marti, H.H., Wenger, R.H., Rivas, L.A., Straumman, U., Digicaylioglu, M., Henn, V., et al. (1996) Erythropoietin gene expression in human,monkey and murine brain. Eur. J. Neurosci. 8, 666.
55. Cai, Z. and Semenza, G.L. (2004) Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109, 2050-2053. (Pubitemid 38620210)
56. Liu, T., Allaf, M., Lagoda, G., and Burnett, A.L. (2007) Erythropoietin receptor expression in the human urogenital tract: immunolocalization in the prostate, neurovascular bundle and penis. BJU Int. 100, 1103-1106. (Pubitemid 47537674)
57. Burnett, A.L., Allaf, M.E., and Bivalacqua, T.J. (2008) Erythropoietin promotes erection recovery after nerve-sparing radical prostatectomy: a retrospective analysis. J. Sex. Med. 10, 2392-2398.
58. Quinlan, D., Nelson, R.J., and Walsh, P. (1991) Cavernous nerve grafts restore erectile function in desnervated rats. J. Urol. 145, 380-384.
59. Walsh, P. (2001) Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 57, 1020-1024.
60. Chang, D.W., Wood, C.G., Kroll, S.S., Youssef, A.A., and Babaian, R.J. (2003) Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study. Plast. Reconstr. Surg. 111, 1174-1181. (Pubitemid 36297416)
61. Scardino, P. and Kim, E.R. (2001) Rationale for and results of nerve cavernous grafting during radical prostatectomy. Urology 57, 1016-1019. (Pubitemid 32455558)
62. Burnett, A.L., Montorsi, F., Briganti, A., Teloken, P., and Whitehurst, T. (2008) Intraoperative assessment of a implantable electrode array for cavernous nerve stimulation. J. Sex. Med. 5, 1949-1954.
63. Sudano, I., Lukas, E.S., Hermann, F., Flammer, A., Corti, R., Noll, G., et al. (2006) Protection of endothelial function: targets for nutritional and pharmacological interventions. J. Cardiovasc. Pharmacol. 47, S136. (Pubitemid 44620204)
64. Hong, S.K., Han, B.K., Jeong, S.J., Byun, S.S., and Lee, S.E. (2007) Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. J. Urol. 178, 613-616.
65. Bella, A.J., Lin, G., Cagiannos, I., and Lue, T.F. (2008) Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury. Asian J. Androl. 10, 54-59.
66. Christ, G.J. (2003) Frontiers in gene therapy for erectile dysfunction. Int. J. Impot. Res. 15(Suppl 5), 33-40.
67. Melman, A., Bar-Chama, N., McCullough, A., Daves, K., and Christ, G. (2006) hMaxi-K gene transfer in males with erectile dyfunction: results of the first human trial. Hum. Gene Ther. 17, 1165-1176. (Pubitemid 44975134)
68. Ahluwalia, A., Buckingham, J.C., Croxtall, J.D., Flower, R.J., Goulding, N.J., and Perretti, M. (1996) In Annexins: Molecular Structure to Cellular Function. Seaton, B.A., Ed. R.G. Landes, Austin, TX. pp. 161-199.
69. Oliani, S.M., Paul-Clark, M.J., Christian, H., Flower, R.J., and Perretti, M. (2001) Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158, 603-615. (Pubitemid 32158621)
70. Kamal, A., Flower, R.J., and Perretti, M. (2005) An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem. Inst. Oswaldo Cruz 100(Suppl 1), 39-47.
71. D'Amico, M., Di Filippo, C., Solito, E., Flower, R.J., Oliani, S.M., Perretti, M., et al. (2000) Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J. 14, 1867-1869. (Pubitemid 30747240)
72. Gavins, F.N., Dalli, J., Flower, R.J., Granger, D.N., and Perretti, M. (2007) Activation of the annexin 1 counterregulatory circuit affords protection in the mouse brain microcirculation. FASEB J. 21, 1751-1758. (Pubitemid 46855621)